Rhino 7 Platinum 3000 — Class I drug recall D-0772-2016
Terminated recall by Tf Supplements, reported 2016-03-16, distributed nationwide. Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.
| Recall number | D-0772-2016 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Tf Supplements, Houston, TX, United States |
| Recall initiated | 2015-09-25 |
| Classified | 2016-03-09 |
| Reported by FDA | 2016-03-16 |
| Terminated | 2022-05-19 |
| Distributed | Nationwide (US) |
| Quantity | 128 blister |
| Reason classes | undeclared allergen, unapproved product |
| UPC / GTIN / UDI-DI | 00700729253748 |
Product
Rhino 7 Platinum 3000, 1 count Blister Pack, Distributed by Rhino 7, Made in USA, UPC 700729253748
Reason for recall
Marketed without an Approved NDA/ANDA: Products contain undeclared desmethyl carbondenafil and dapoxetine.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0772-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.